Table 6 Costs by NYHA stage
From: Cost-of-illness studies in heart failure: a systematic review 2004–2016
Reference | Year of cost data | Country | NYHA I | NYHA II | NYHA III | NYHA IV | Total costs per patient and year |
|---|---|---|---|---|---|---|---|
local currency in year of costs/ local currency in 2016/ $US in 2016, PPP | |||||||
Delgado, 2013 (direct costs) | 2010 | Spain | – | 3789€/ 4028€/ 6075$ | 6832€/ 7262€/ 10,953$ | 4860€/ 5166€/ 7792$ | |
Delgado, 2013 (total costs) | 2010 | Spain | – | 10,283–14,459€/ 10,931–15,370€/ 16,487–23,183$ | 18,265–23,721€/ 19,416–25,215€/ 29,285–38,032$ | 12,995–18,220€/ 13,814–19,368€/ 20,836–29,213$ | |
Czech, 2013 [36] | 2010 | Poland | a | 5,315PLN/ 5,708PLN/ 3265$ | 8,116PLN/ 8,717PLN/ 4987$ | 21,273PLN/ 22,847PLN/ 13,070$ | 7739PLN/ 8312PLN/ 4755$ |